Management ChangeMay 14, 2026, 08:06 AM
Prenetics Appoints Brian J. Rosin as U.S. CFO for IM8
AI Summary
Prenetics Global Ltd, parent company of the premium health and longevity brand IM8, announced the appointment of Brian J. Rosin as U.S. Chief Financial Officer. Mr. Rosin will lead the finance organization, reporting to CEO Danny Yeung, and will establish dedicated finance leadership for IM8 to support its rapid global expansion. IM8, co-founded with David Beckham, is projecting $190 million to $210 million in revenue for 2026, its second year from launch, and has already surpassed $100 million in annualized recurring revenue within 11 months. Rosin brings nearly two decades of financial leadership in consumer e-Commerce and premium wellness brands.
Key Highlights
- Prenetics appointed Brian J. Rosin as U.S. Chief Financial Officer for IM8.
- Mr. Rosin brings nearly two decades of financial leadership experience.
- IM8 projects $190 million to $210 million in revenue for 2026.
- IM8 surpassed $100 million in annualized recurring revenue within 11 months.
- IM8 is currently sold in more than 40 countries worldwide.